JP2017522283A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017522283A5 JP2017522283A5 JP2016572477A JP2016572477A JP2017522283A5 JP 2017522283 A5 JP2017522283 A5 JP 2017522283A5 JP 2016572477 A JP2016572477 A JP 2016572477A JP 2016572477 A JP2016572477 A JP 2016572477A JP 2017522283 A5 JP2017522283 A5 JP 2017522283A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- pharmaceutical composition
- water
- surfactant
- propylene glycol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 13
- 239000004094 surface-active agent Substances 0.000 claims 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 6
- 150000002646 long chain fatty acid esters Chemical class 0.000 claims 5
- 239000002736 nonionic surfactant Substances 0.000 claims 5
- 229960000746 testosterone undecanoate Drugs 0.000 claims 4
- UDSFVOAUHKGBEK-CNQKSJKFSA-N testosterone undecanoate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CCCCCCCCCC)[C@@]1(C)CC2 UDSFVOAUHKGBEK-CNQKSJKFSA-N 0.000 claims 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 3
- OVYMWJFNQQOJBU-UHFFFAOYSA-N 1-octanoyloxypropan-2-yl octanoate Chemical compound CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC OVYMWJFNQQOJBU-UHFFFAOYSA-N 0.000 claims 2
- GHHURQMJLARIDK-UHFFFAOYSA-N 2-hydroxypropyl octanoate Chemical compound CCCCCCCC(=O)OCC(C)O GHHURQMJLARIDK-UHFFFAOYSA-N 0.000 claims 2
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 claims 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 2
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 claims 2
- 229940093471 ethyl oleate Drugs 0.000 claims 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims 2
- 239000008389 polyethoxylated castor oil Substances 0.000 claims 2
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 claims 1
- NFIHXTUNNGIYRF-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCC NFIHXTUNNGIYRF-UHFFFAOYSA-N 0.000 claims 1
- ZVTDEEBSWIQAFJ-KHPPLWFESA-N 2-hydroxypropyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C)O ZVTDEEBSWIQAFJ-KHPPLWFESA-N 0.000 claims 1
- JZSMZIOJUHECHW-GTJZZHROSA-N 2-hydroxypropyl (z,12r)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC(=O)OCC(C)O JZSMZIOJUHECHW-GTJZZHROSA-N 0.000 claims 1
- BHIZVZJETFVJMJ-UHFFFAOYSA-N 2-hydroxypropyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(C)O BHIZVZJETFVJMJ-UHFFFAOYSA-N 0.000 claims 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims 1
- 206010058359 Hypogonadism Diseases 0.000 claims 1
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- 235000011187 glycerol Nutrition 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims 1
- 229920000053 polysorbate 80 Polymers 0.000 claims 1
- 229940068968 polysorbate 80 Drugs 0.000 claims 1
- 229940026235 propylene glycol monolaurate Drugs 0.000 claims 1
- 239000001593 sorbitan monooleate Substances 0.000 claims 1
- 235000011069 sorbitan monooleate Nutrition 0.000 claims 1
- 229940035049 sorbitan monooleate Drugs 0.000 claims 1
- 239000000600 sorbitol Substances 0.000 claims 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical group CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14172805.5 | 2014-06-17 | ||
| EP14172805 | 2014-06-17 | ||
| PCT/EP2015/063292 WO2015193224A1 (en) | 2014-06-17 | 2015-06-15 | Stable formulations of testosterone undecanoate |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017522283A JP2017522283A (ja) | 2017-08-10 |
| JP2017522283A5 true JP2017522283A5 (enExample) | 2018-07-26 |
| JP6618488B2 JP6618488B2 (ja) | 2019-12-11 |
Family
ID=50980940
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016572477A Expired - Fee Related JP6618488B2 (ja) | 2014-06-17 | 2015-06-15 | テストステロンウンデカノエートの安定な製剤 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9925200B2 (enExample) |
| EP (1) | EP3157505B1 (enExample) |
| JP (1) | JP6618488B2 (enExample) |
| KR (1) | KR20170020779A (enExample) |
| CN (1) | CN106456782B (enExample) |
| AU (1) | AU2015276321B2 (enExample) |
| BR (1) | BR112016028192A2 (enExample) |
| CA (1) | CA2950670A1 (enExample) |
| ES (1) | ES2749008T3 (enExample) |
| MX (1) | MX373197B (enExample) |
| RU (1) | RU2708238C2 (enExample) |
| WO (1) | WO2015193224A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2519230T3 (pl) | 2009-12-31 | 2019-05-31 | Marius Pharmaceuticals Llc | Modulacja rozpuszczalności, stabilności, absorpcji, metabolizmu i profilu farmakokinetycznego leków lipofilowych przez sterole |
| CN105188670B (zh) | 2013-03-15 | 2018-11-02 | 马留斯医药有限责任公司 | 乳液制剂 |
| CN111432805B (zh) | 2017-11-27 | 2023-02-17 | 梅克里内科尼蒂翁公司 | 3α-乙炔基-3β-羟基雄甾烷-17-酮肟的药物制剂 |
| US12150945B2 (en) | 2018-07-20 | 2024-11-26 | Lipocine Inc. | Liver disease |
| US12403146B2 (en) | 2019-10-30 | 2025-09-02 | Marius Pharmaceuticals, Inc. | Preferred oral testosterone undecanoate therapy to achieve testosterone replacement treatment |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4147783A (en) | 1974-02-28 | 1979-04-03 | Akzona Incorporated | Oral pharmaceutical preparation |
| US4098802A (en) | 1975-02-18 | 1978-07-04 | Akzona Incorporated | Oral pharmaceutical preparation having androgenic activity |
| NL189235C (nl) | 1974-02-28 | 1993-02-16 | Akzo Nv | Werkwijze voor de bereiding van een oraal toe te dienen farmaceutisch preparaat met androgene werking. |
| NL7510104A (nl) | 1975-08-27 | 1977-03-01 | Akzo Nv | Werkwijze ter bereiding van een oraal werkzaam farmaceutisch preparaat. |
| US5532002A (en) | 1989-08-17 | 1996-07-02 | Cortecs Limited | Gelatin pharmaceutical formulations |
| ATE113471T1 (de) | 1989-08-17 | 1994-11-15 | Cortecs Ltd | Arzneiformulierungen. |
| CN1102095A (zh) | 1993-10-30 | 1995-05-03 | 浙江医科大学 | 长效雄激素类制剂——十一酸睾丸注射液 |
| GB9405304D0 (en) | 1994-03-16 | 1994-04-27 | Scherer Ltd R P | Delivery systems for hydrophobic drugs |
| GB9608719D0 (en) * | 1996-04-26 | 1996-07-03 | Scherer Ltd R P | Pharmaceutical compositions |
| SE9700642D0 (sv) | 1997-02-24 | 1997-02-24 | Kronvall Stefan Med Ab | Medel och sätt för förebyggande och behandling av det metabola syndromet |
| CN1208047C (zh) | 1997-07-29 | 2005-06-29 | 法玛西雅厄普约翰美国公司 | 亲脂性化合物的自体乳化剂 |
| US7396526B1 (en) * | 1998-11-12 | 2008-07-08 | Johnson & Johnson Consumer Companies, Inc. | Skin care composition |
| GB9907715D0 (en) | 1999-04-01 | 1999-05-26 | Scherer Corp R P | Pharmaceutical compositions |
| US6652880B1 (en) * | 1999-04-01 | 2003-11-25 | R.P. Scherer Technologies, Inc. | Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants |
| RU2246296C2 (ru) | 1999-04-01 | 2005-02-20 | Акцо Нобель Н.В. | Композиция, включающая ундеканоат тестостерона и касторовое масло |
| RU2303981C2 (ru) * | 2000-11-01 | 2007-08-10 | Юнимед Фармасьютикалс, Инк. | Способ лечения эректильной дисфункции и повышения либидо у мужчин |
| KR20070084531A (ko) * | 2004-11-24 | 2007-08-24 | 머크 앤드 캄파니 인코포레이티드 | 치환된 아미드의 경구 투여용 액체 및 반고체 약제학적제형 |
| US8492369B2 (en) | 2010-04-12 | 2013-07-23 | Clarus Therapeutics Inc | Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same |
| WO2006113505A2 (en) | 2005-04-15 | 2006-10-26 | Clarus Therapeutics, Inc. | Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same |
| US20130303495A1 (en) * | 2009-12-31 | 2013-11-14 | Sov Therapeutics | Emulsion formulations |
| PL2519230T3 (pl) * | 2009-12-31 | 2019-05-31 | Marius Pharmaceuticals Llc | Modulacja rozpuszczalności, stabilności, absorpcji, metabolizmu i profilu farmakokinetycznego leków lipofilowych przez sterole |
| SG184540A1 (en) | 2010-04-12 | 2012-11-29 | Clarus Therapeutics Inc | Oral testosterone ester formulations and methods of treating testoterone deficiency comprising same |
| US9034858B2 (en) * | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US20120135074A1 (en) * | 2010-11-30 | 2012-05-31 | Chandrashekar Giliyar | High-Strength Testosterone Undecanoate Compositions |
| CA2905703A1 (en) | 2013-03-15 | 2014-09-18 | Clarus Therapeutics, Inc. | Methods of treating testosterone deficiency |
| US10245273B2 (en) | 2013-12-26 | 2019-04-02 | Clarus Therapeutics, Inc. | Oral pharmaceutical products and methods of use combining testosterone esters with hypolipidemic agents |
-
2015
- 2015-06-15 EP EP15728552.9A patent/EP3157505B1/en active Active
- 2015-06-15 KR KR1020167035025A patent/KR20170020779A/ko not_active Withdrawn
- 2015-06-15 CA CA2950670A patent/CA2950670A1/en not_active Abandoned
- 2015-06-15 WO PCT/EP2015/063292 patent/WO2015193224A1/en not_active Ceased
- 2015-06-15 JP JP2016572477A patent/JP6618488B2/ja not_active Expired - Fee Related
- 2015-06-15 US US15/317,132 patent/US9925200B2/en active Active
- 2015-06-15 AU AU2015276321A patent/AU2015276321B2/en not_active Ceased
- 2015-06-15 MX MX2016016612A patent/MX373197B/es active IP Right Grant
- 2015-06-15 CN CN201580032121.7A patent/CN106456782B/zh not_active Expired - Fee Related
- 2015-06-15 ES ES15728552T patent/ES2749008T3/es active Active
- 2015-06-15 BR BR112016028192A patent/BR112016028192A2/pt not_active Application Discontinuation
- 2015-06-15 RU RU2017101240A patent/RU2708238C2/ru active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2017101240A (ru) | Стабильные составы тестостерона ундеканоата | |
| HRP20211130T1 (hr) | Transmukozni i transdermalni sustavi za isporuku | |
| JP2013508296A5 (enExample) | ||
| WO2015184127A3 (en) | Stable cannabinoid formulations | |
| MX369229B (es) | Metodo para desinfectar semillas comestibles, particularmente semillas productoras de mucilago. | |
| JP2015520235A5 (enExample) | ||
| JP2014509655A5 (enExample) | ||
| FR3024037B1 (fr) | Ingredient actif cosmetique ou dermatologique comprenant un melange d'acides dicarboxyliques gras insatures, compositions le comprenant et utilisations cosmetiques ou dermatologiques | |
| AR083864A1 (es) | Producto para el cuidado oral y metodo para su uso y fabricacion | |
| ES2661577T3 (es) | Mezclas de material de planta de mostaza para el control de plagas y métodos de preparación | |
| RU2019126797A (ru) | Составы твердых дозированных лекарственных форм антагониста орексинового рецептора | |
| AR092566A1 (es) | Composiciones grasas para mantener una palatabilidad de alimentos para animales domesticos en el tiempo | |
| HK1258390A1 (zh) | 口服紫杉烷组合物和方法 | |
| ES2531243T3 (es) | Composiciones potenciadoras del frescor | |
| ME03389B (me) | Paraziticidne oralne veterinarske kompozicije које sadrže sistemski-delujuća aktivna sredstva, metodi i primene isтih | |
| JP2013525485A5 (enExample) | ||
| ES2643493T3 (es) | Composiciones sólidas en forma de polvos o granulados para la administración oral de ingredientes activos y método para obtenerlas | |
| CL2017000475A1 (es) | Composición para formulación cosmética que consiste en una mezcla de hasta 3 componentes seleccionados de manteca de murumuru, manteca de ucuuba, aceite de nuez de brasil, aceite de maracuyá, manteca de copoazú, aceite de acai y aceite de andiroba y/o ésteres de los mismos; producto cosmético. | |
| FI3041579T3 (fi) | Suun kautta annettavia loislääkekoostumuksia | |
| JP2016519101A5 (enExample) | ||
| CL2011003235A1 (es) | Alimento de peces que contiene por lo menos un antioxidante soluble en agua seleccionado del grupo acidos hidroxicinamicos o acidos hidrobenzoicos, contiene hasta 40 mg de pigmento por kilo de alimento de por lo menos un pigmento seleccionado del grupo que comprende astaxantina o cantaxantina. | |
| RU2015116260A (ru) | Неводные составы нанодисперсии таксанов и способы их применения | |
| HRP20170372T1 (hr) | Prostirka za papkare i njezino recikliranje u kompost | |
| HK1244218A1 (zh) | 包括多不饱和游离脂肪酸的毫米胶囊配制品 | |
| JP2016529902A5 (enExample) |